PharmaShots | Incisive News in 3 Shots

Subscribe Now

U.S.FDA

Foundation Medicine's FoundationOne CDx Receives the US FDA's Approval as a CDx for Vitrakvi (larotrectinib)

Foundation Medicine's FoundationOne CDx Receives the US FDA's Approval as a CDx for Vitrakvi (larotrectinib)

October 26, 2020

Novartis's Branaplam (LMI070) Receives the US FDA's Orphan Drug Designation for Huntington's Disease

Novartis's Branaplam (LMI070) Receives the US FDA's Orphan Drug Designation for Huntington's Disease

October 22, 2020

$Merck's Keytruda (pembrolizumab) Receives the US FDA's Approval for Relapsed or Refractory Classical Hodgkin Lymphoma$

Merck's Keytruda (pembrolizumab) Receives the US FDA's Approval for Relapsed or Refractory Classical Hodgkin Lymphoma

October 16, 2020

Regeneron's Inmazeb (atoltivimab- maftivimab- and odesivimab) Receives the US FDA's Approval as the First Treatment for Ebola

Regeneron's Inmazeb (atoltivimab- maftivimab- and odesivimab) Receives the US FDA's Approval as the First Treatment for Ebola

October 15, 2020

Abbott's AdviseDx SARS-CoV-2 IgM Test Receives the US FDA's EUA for COVID-19

Abbott's AdviseDx SARS-CoV-2 IgM Test Receives the US FDA's EUA for COVID-19

October 13, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us